EDAP TMS
Yahoo Finance • 12 months ago
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
LYON, France, November 30, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that is has received the Industry Category Award from the French National Institute for Intellectu... Full story
Yahoo Finance • last year
EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
LYON, France, November 20, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host... Full story
Yahoo Finance • last year
EDAP Announces Third Quarter 2023 Financial Results
- Strong Q3 2023 U.S. Focal One® HIFU procedure growth of +150% year-over-year - - Record nine months HIFU revenues reflecting growing demand - - Two additional Focal One systems already placed in the fourth quarter - - Announces immuno... Full story
Yahoo Finance • last year
EDAP to Present at the Jefferies London Healthcare Conference
LYON, France, November 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1... Full story
Yahoo Finance • last year
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
Company to host conference call and webcast on Thursday, November 9th at 8:30am EDT LYON, France, October 26, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it... Full story
Yahoo Finance • last year
EDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference
LYON, France, September 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host... Full story
Yahoo Finance • last year
EDAP Announces Second Quarter 2023 Financial Results
- Record second quarter and first half revenues of EUR 14.3 million (USD 15.5 million) and EUR 29.1 million (USD 31.5 million), respectively- - Total HIFU Q2 2023 year-over-year revenue growth of 63.6%- - Strong Q2 2023 year-over-year U.... Full story
Yahoo Finance • 2 years ago
EDAP Announces First Quarter 2023 Financial Results
- Record first quarter revenue - - Positive results from two studies reconfirm safety and efficacy of Focal One- - Company to host conference call and webcast today, Wednesday, May 17that 8:30 am EDT - LYON, France, May 17, 2023 - EDAP... Full story
Yahoo Finance • 2 years ago
EDAP to Announce First Quarter 2023 Financial Results on May 17, 2023
- Company to host conference call and webcast on Wednesday, May 17that 8:30 am EDT - LYON, France, May 3, 2023 - EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will... Full story
Yahoo Finance • 2 years ago
EDAP Announces Major Presence at Upcoming Annual Meeting of the American Urological Association (AUA)
Meeting to Showcase EDAP’s Focal One® Robotic High Intensity Focused Ultrasound (HIFU)Platform for the Management of Prostate Cancer LYON, France, April 21, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic... Full story
Yahoo Finance • 2 years ago
EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience
Leading Center Demonstrates Focal HIFU as a Tool in The Management of Prostate Cancer Webcast scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT) LYON, France, April 10, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”),... Full story
Yahoo Finance • 2 years ago
EDAP Announces Regulatory Clearance of ExactVu Micro-Ultrasound in Japan
Allows for market launch of the only micro-ultrasound platform for precision prostate biopsies LYON, France, April 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in robotic energy-based therapies, today provided a... Full story
Yahoo Finance • 2 years ago
EDAP TMS S.A. (NASDAQ:EDAP) Q4 2022 Earnings Call Transcript
EDAP TMS S.A. (NASDAQ:EDAP) Q4 2022 Earnings Call Transcript March 30, 2023 Operator: Ladies and gentlemen, greetings, and welcome to the EDAP TMS Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participant l... Full story
Yahoo Finance • 2 years ago
EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy
Record full-year 2022 total revenue of EUR 55.1 million ($58.0 million) increased 25.1% over full-year 2021Full-year HIFU revenue was EUR 15.6 million (USD 16.4 million), an increase of 57.7% as compared to EUR 9.9 million (USD 11.7 millio... Full story
Yahoo Finance • 2 years ago
EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23
Results demonstrate salvage treatment free survival rate (STFS) at 30 months of 90.1% in the HIFU-treated arm versus 86.8% in patients who underwent radical prostatectomy (RP) The HIFU treated arm showed significant benefits across multip... Full story
Yahoo Finance • 2 years ago
EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th
LYON, France, March 9, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full-year ended December... Full story
Yahoo Finance • 2 years ago
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue
Record full-year 2022 total preliminary unaudited revenue of €55.1 million ($58.0 million) represents an increase of 25.1% over full-year 2021, driven by 58.1% HIFU growth Record Q4 2022 total preliminary unaudited revenue of €15.8 millio... Full story
Yahoo Finance • 2 years ago
EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis
Focal One® HIFU treatment resulted in significant improvements in endometriosis symptoms and quality of life (QoL) Positive safety profile with 96.7% ofpatients with no ornon-significant adverse events Data was presented at theParis Sant... Full story
Yahoo Finance • 2 years ago
EDAP Announces Record Q4 US Focal One Placements
Company preliminarily reports nine Focal One Placements in the U.S., including seven sales LYON, France, January 5, 2023 -- EDAP TMS SA (NASDAQ: EDAP) (the “Company”), the global leader in robotic energy-based therapies, announced today t... Full story
Yahoo Finance • 2 years ago
EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary
LYON, France, December 6, 2022 -- EDAP TMS SA (NASDAQ: EDAP) (the “Company”), the global leader in robotic energy-based therapies, announced today that the Company has hired medical capital equipment finance industry veteran Ken Mobeck as... Full story
